The trial findings complement the updated US dyslipidemia guidelines that promote early and intensive LDL lowering.

For patients with uncontrolled hypertension already on two or more medications, monthly injections of tonlamarsen (Kardigan) more effectively lowered plasma angiotensinogen (AGT) levels than a single ...

Monthly injections of tonlamarsen lowered AGT but didn’t reduce BP in patients already on multiple antihypertensive drugs.

Physicians wrestled with endpoint composition, low event rates, a possible difference in ischemic strokes, and more.

Patients with acute intermediate-risk pulmonary embolism (PE) have better short-term outcomes with ultrasound-facilitated, catheter-directed fibrinolysis plus heparin-based anticoagulation compared ...

In the STEMI Door-to-Unload trial, use of Impella missed the mark in patients with anterior MI without cardiogenic shock.

They look to establish minimum volumes for hospitals and operators seeking to start and maintain TTVI programs.

The final results of RECOVERY add support to addressing severe aortic stenosis right away rather than waiting for symptoms.

High fat volume was linked to plaque presence and progression, but more work is needed to clarify clinical use.

This marks the first dedicated transcatheter heart valve approved for high-risk patients with symptomatic severe AR.

Researchers confirmed a four-biomarker model is more informative at younger vs older ages, with slight sex differences.